Elon Musk confirms that the pioneer Neuralink recipient can now manipulate a mouse using their mind

Elon Musk's Neuralink

In a recent update on one of his most ambitious ventures, Elon Musk revealed encouraging progress from Neuralink’s first human trial. Musk announced that the initial recipient of the neuralink brain chip implant, conducted last month, has fully recovered and can now control a computer mouse through their thoughts.

During a Spaces event on the social media platform X, Musk reported, “Progress was positive, and the patient has recovered fully, with no apparent adverse neural effects. The individual could manipulate a mouse on the screen simply by thinking.”

While celebrating this milestone, Musk emphasized Neuralink’s broader objectives. The company aims to enable more intricate interactions, such as controlling mouse buttons using the patient’s thoughts.

Earlier in January, Musk had announced the successful implantation of a chip in Neuralink’s first human patient. The approval for human trial recruitment was obtained in September, marking a significant step for the project.

Although the patient’s identity remains undisclosed, Neuralink’s September announcement specified the target demographic as individuals suffering from quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s Disease.

Neuralink employs a robot to surgically implant a brain-computer interface in a brain region responsible for movement intention. The initial goal is to enable individuals to control a computer cursor or keyboard using their thoughts.

For Musk, Neuralink represents a grand ambition aimed at facilitating rapid surgical insertions of chip devices to address conditions such as obesity, autism, depression, and schizophrenia.

Founded by Elon Musk in 2016, Neuralink is a neurotechnology company focused on creating a seamless brain-computer interface (BCI) known as “the Link.” This technology assists individuals with neurological conditions or traumatic injuries in regaining control of electronic devices using their thoughts alone.

The Link is a coin-sized chip surgically implanted with ultra-thin wires connecting it to specific brain regions involved in movement intentions. It decodes and stimulates neural activity, translating thought into action.

Neuralink’s initial product, “Telepathy,” aims to enable users to control phones and computers directly with their minds. However, the company’s aspirations extend to restoring movement, sensory, and visual functions, as well as treating neurological disorders.

Despite a valuation of $5 billion, Neuralink faces ongoing scrutiny regarding its safety measures. Recent reports have raised concerns about regulatory violations related to hazardous material transportation, underscoring the importance of careful evaluation before widespread implementation.